Natco seeks CDSCO approval for Phase III trial of Molnupiravir for COVID-19 treatment
Drug major Natco Pharma on Monday said it has sought approval from the Central Drugs Standard Control Organisation (CDSCO) in India for the Phase III clinical trial of Molnupiravir capsules…